Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Therapeutics, Inc. Lawsuit - NTLA
Portfolio Pulse from
Law firm Levi & Korsinsky has announced a class action securities lawsuit against Intellia Therapeutics (NTLA), alleging securities fraud between July 30, 2024, and January 8, 2025. Shareholders are being notified of a lead plaintiff deadline of April 14, 2025, to potentially recover investment losses.
March 21, 2025 | 10:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The class action lawsuit could potentially impact investor confidence and stock performance for Intellia Therapeutics.
Class action lawsuits can negatively impact a company's stock price by creating uncertainty, potential financial liability, and eroding investor trust. The specific allegations of securities fraud between July 2024 and January 2025 suggest significant potential legal and financial risks.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100